Health perceptions and clinical characteristics of relapsing-remitting multiple sclerosis patients: baseline data from an international clinical trial

References

• Miller DM, Cohen JA, Kooijmans M, et al., for the IMPACT Investigators. Change in clinician-assessed measures of multiple sclerosis and subject-reported quality of life: results from the impact study. Mult Scler 2006;12:180-6
   PubMed Web of Science ®Google Scholar
• Visschedijk MA, Uitdehaag BM, Klein M, et al. Value of health-related quality of life to predict disability course in multiple sclerosis. Neurology 2004;63:2046-50
   PubMed Web of Science ®Google Scholar
• Rudick RA, Miller D, Hass S, et al. Health-related quality of life in multiple sclerosis: effects of natalizumab. Ann Neurol 2007;62:335-46
   PubMed Web of Science ®Google Scholar
• Nortvedt MW, Riise T, Frugard J, et al. Prevalence of bladder, bowel and sexual problems among multiple sclerosis patients two to five years after diagnosis. Mult Scler 2007;13:106-12
   PubMed Web of Science ®Google Scholar
• Visschedijk MAJ, Uitdehagg BMJ, Klein M, et al. Value of health-related quality of life to predict disability course in multiple sclerosis. Neurol 2004;63:2046-50
   PubMed Web of Science ®Google Scholar
• Segal BM, Constantinescu CS, Raychaudhuri A, et al., for the Ustekinumab MS Investigators. Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study. Lancet Neurol 2008;7:796-804
   PubMed Web of Science ®Google Scholar
• Cutter GR, Baier ML, Rudick RAC, et al. Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain 1999;122:871-82
   PubMed Web of Science ®Google Scholar
• Hoogervorst EL, Eikelenboom MJ, Uitdehaag BM, et al. One year changes in disability in multiple sclerosis: neurological examination compared with patient self report. J Neurol Neurosurg Psychiatry 2003;74:439-42
   PubMed Web of Science ®Google Scholar
• Hoogervorst EL, Kalkers NF, Cutter GR, et al. The patient's perception of a (reliable) change in the multiple sclerosis functional composite. Mult Scler 2004;10:55-60
   PubMed Web of Science ®Google Scholar
• Krupp LB, Alvarez LA, LaRocca NG, et al. Fatigue in multiple sclerosis. Arch Neurol 1988;45:435-7
   PubMed Web of Science ®Google Scholar
• Krupp LB, LaRocca NG, Muir-Nash J, et al. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989;46:1121-3
   Google Scholar
• Fischer JS, LaRocca NG, Miller DM, et al. Recent developments in the assessment of quality of life in multiple sclerosis (MS). Mult Scler 1999;5:251-9
   PubMed Web of Science ®Google Scholar
• Marrie RA, Miller DM, Chelune GJ, et al. Validity and reliability of the MSQLI in cognitively impaired patients with multiple sclerosis. Mult Scler 2003;9:621-6
   PubMed Web of Science ®Google Scholar
• Miller A, Dishon S. Health-related quality of life in multiple sclerosis: the impact of disability, gender and employment status. Qual Life Res 2006;15:259-71
   PubMed Web of Science ®Google Scholar
• Flachenecker P, Kumpfel T, Kallmann B, et al. Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters. Mult Scler 2002;8:523-6
   PubMed Web of Science ®Google Scholar
• National multiple sclerosis society. <www.nationalmssociety.org>. Accessed February, 2008
   Google Scholar
• Ware JE Jr, Kosinski M, Keller SD. SF-36 Physical & Mental Health Summary Scales: a User's Manual of version 1, 2nd edn. Lincoln, RI: QualityMetric Incorporated, 2001
   Google Scholar
• Kragt JJ, Nielsen JM, van der Linden FA, et al. How similar are commonly combined criteria for EDSS progression in multiple sclerosis? Mult Scler 2006;12:782-6
   PubMed Web of Science ®Google Scholar
• Guyatt GH, Osoba D, Wu AW, et al. Methods to explain the clinical significance of health status measures. Mayo Clin Proc 2002;77:371-83
   PubMed Web of Science ®Google Scholar
• Revicki DA, Cella D, Hays RD. Responsiveness and minimal important differences for patient reported outcomes. Health Qual Life Outcomes 2006;4:70
   PubMed Web of Science ®Google Scholar
• Cohen J. Statistical Power Analysis for the Behavioral Sciences, 2nd edn. Hillsdale, NJ: Lawrence Erlbaum Associates, 1988
   Google Scholar
• Revicki D, Hays RD, Cella D, et al. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol 2008;61:102-9
   PubMed Web of Science ®Google Scholar
• Sloan JA, Cella D, Hays RD. Clinical significance of patient-reported questionnaire data: another step toward consensus. J Clin Epidemiol 2005;58:1217-19
   PubMed Web of Science ®Google Scholar
• Heesen C, Nawrath L, Reich C, et al. Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour? J Neurol Neurosurg Psychiatry 2006;77:34-9
   PubMed Web of Science ®Google Scholar
• Merkelbach S, Sittinger H, Koenig J. Is there a differential impact of fatigue and physical disability on quality of life in multiple sclerosis? J Nerv Ment Dis 2002;190:388-93
   PubMed Web of Science ®Google Scholar
• Roxburgh RH, Seaman SR, Masterman T, et al. Multiple sclerosis severity score: using disability and disease duration to rate disease severity. Neurology 2005;64:1144-51
   PubMed Web of Science ®Google Scholar
• Pittock SJ, Mayr WT, McClelland RL, et al. Quality of life is favorable for most patients with multiple sclerosis: a population-based cohort study. Arch Neurol 2004;61:679-86
   PubMed Web of Science ®Google Scholar
• Hopman WM, Coo H, Edgar CM, et al. Factors associated with health-related quality of life in multiple sclerosis. Can J Neurol Sci 2007;34:160-6
   PubMed Web of Science ®Google Scholar
• Amato MP, Zipoli V, Goretti B, et al. Benign multiple sclerosis: cognitive, psychological and social aspects in a clinical cohort. J Neurol 2006;253:1054-9
   PubMed Web of Science ®Google Scholar
• Benedict RH, Wahlig E, Bakshi R, et al. Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change. J Neurol Sci 2005;231:29-34
   PubMed Web of Science ®Google Scholar
• Ramsaransing GS, De Keyser J. Predictive value of clinical characteristics for 'benign' multiple sclerosis. Eur J Neurol 2007;14:885-9
   PubMed Web of Science ®Google Scholar
• Sayao AL, Devonshire V, Tremlett H. Longitudinal follow-up of “benign” multiple sclerosis at 20 years. Neurology 2007;68:496-500
   PubMed Web of Science ®Google Scholar
• Simioni S, Ruffieux C, Bruggimann L, et al. Cognition, mood and fatigue in patients in the early stage of multiple sclerosis. Swiss Med Wkly 2007;137:496-501
   PubMed Web of Science ®Google Scholar
• Johansson S, Ytterberg C, Claesson IM, et al. High concurrent presense of disability in multiple sclerosis. Associations with perceived health. J Neurol 2007;254:767-73
   Google Scholar
• Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life. The remarkable universality of half a standard deviation. Med Care 2003;41:582-92
   Google Scholar
• Ytterberg C, Johansson S, Andersson M, et al. Variations in functioning and disability in multiple sclerosis: a two-year prospective study. J Neurol 2008;255:967-73
   PubMed Web of Science ®Google Scholar
• Ytterberg C, Johansson S, Widen Holmqvist L, et al. Longitudinal variations and predictors of increased perceived impact of multiple sclerosis, a two-year study. J Neurol Sci 2008;270:53-9
   PubMed Web of Science ®Google Scholar